
Nidan Laboratories & Healthcare Ltd is Rated Strong Sell
2025-12-26 15:13:38Nidan Laboratories & Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Nidan Laborator. Evaluation Revised Amid Mixed Financial and Technical Signals
2025-12-08 10:10:51Nidan Laborator., a microcap player in the hospital sector, has undergone a revision in its market assessment reflecting shifts in its fundamental and technical outlook. This update highlights nuanced changes across quality, valuation, financial trends, and technical indicators, providing investors with a clearer understanding of the stock’s current positioning within a challenging market environment.
Read full news article
Nidan Laboratories & Healthcare: Valuation Metrics Reflect Shift in Market Assessment
2025-12-01 08:02:25Nidan Laboratories & Healthcare has experienced a notable revision in its valuation parameters, with key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV) indicating a shift from previously attractive levels to a more moderate assessment. This article examines these changes in the context of the hospital sector and peer comparisons, providing insight into the stock’s current market positioning.
Read full news article
Nidan Laboratories & Healthcare Hits Upper Circuit Amid Strong Buying Pressure
2025-11-28 11:00:11Nidan Laboratories & Healthcare Ltd witnessed a significant surge in its share price on 28 Nov 2025, hitting the upper circuit limit of 13.68% and closing at ₹21.60. This sharp movement reflects robust buying interest and a notable outperformance relative to its sector and broader market indices.
Read full news article
Nidan Laboratories & Healthcare Surges with Unprecedented Buying Interest, Hits Upper Circuit
2025-11-28 10:20:41Nidan Laboratories & Healthcare Ltd has witnessed extraordinary buying momentum, registering a remarkable 19.74% gain in a single trading session. The stock has hit the upper circuit with only buy orders in the queue, signalling intense demand and a potential multi-day circuit scenario as sellers remain absent from the market.
Read full news articleCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






